Crinetics Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Crinetics Pharmaceuticals, Inc. (CRNX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $21.40 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-03
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $21.40M.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $22.43M.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $23.44M.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $24.50M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $21.40M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $22.43M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $23.44M 10-K · filed 2026-02-26 |
| 2025-09-30 | $24.50M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $25.57M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $26.66M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $27.72M 10-K · filed 2025-02-27 |
| 2024-09-30 | $28.85M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $29.98M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $31.11M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $32.21M 10-K · filed 2024-02-28 |
| 2023-09-30 | $32.45M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $214.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $265.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $320.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $381.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $447.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $517.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $590.00K 10-K · filed 2022-03-30 |
| 2021-03-31 | $838.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $927.00K 10-K · filed 2021-03-30 |
| 2020-09-30 | $1.02M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $1.12M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $1.22M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $1.33M 10-K · filed 2020-03-09 |
| 2019-09-30 | $1.44M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.55M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $1.66M 10-Q · filed 2019-05-13 |